BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12918063)

  • 1. Role of thymidine phosphorylase on invasiveness and metastasis in lung adenocarcinoma.
    Sato J; Sata M; Nakamura H; Inoue S; Wada T; Takabatake N; Otake K; Tomoike H; Kubota I
    Int J Cancer; 2003 Oct; 106(6):863-70. PubMed ID: 12918063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors.
    Matsushita S; Nitanda T; Furukawa T; Sumizawa T; Tani A; Nishimoto K; Akiba S; Miyadera K; Fukushima M; Yamada Y; Yoshida H; Kanzaki T; Akiyama S
    Cancer Res; 1999 Apr; 59(8):1911-6. PubMed ID: 10213500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma.
    Yu EJ; Lee Y; Rha SY; Kim TS; Chung HC; Oh BK; Yang WI; Noh SH; Jeung HC
    Mol Cancer Res; 2008 Oct; 6(10):1554-66. PubMed ID: 18922971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.
    Uchimiya H; Furukawa T; Okamoto M; Nakajima Y; Matsushita S; Ikeda R; Gotanda T; Haraguchi M; Sumizawa T; Ono M; Kuwano M; Kanzaki T; Akiyama S
    Cancer Res; 2002 May; 62(10):2834-9. PubMed ID: 12019161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thymidine phosphorylase and angiogenesis].
    Akiyama S
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1208-11. PubMed ID: 10945018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of metastasis by thymidine phosphorylase inhibitor.
    Takao S; Akiyama SI; Nakajo A; Yoh H; Kitazono M; Natsugoe S; Miyadera K; Fukushima M; Yamada Y; Aikou T
    Cancer Res; 2000 Oct; 60(19):5345-8. PubMed ID: 11034068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
    Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
    Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.
    Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Cox J; Krammer B; Gatter KC; Harris AL
    Clin Exp Metastasis; 1999; 17(7):545-54. PubMed ID: 10845553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidine phosphorylase levels and dihydropyrimidine dehydrogenase levels in non-small cell lung cancer tissues.
    Chujo M; Miura T; Kawano Y; Miyawaki M; Imakiire T; Hayashita Y; Kawahara K
    Oncol Rep; 2006 Oct; 16(4):777-80. PubMed ID: 16969493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of the antitumor activity of alpha, alpha, alpha-trifluorothymidine by the co-administration of an inhibitor of thymidine phosphorylase at a suitable molar ratio in vivo.
    Emura T; Suzuki N; Fujioka A; Ohshimo H; Fukushima M
    Int J Oncol; 2005 Aug; 27(2):449-55. PubMed ID: 16010427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitization by thymidine phosphorylase inhibitor in thymidine phosphorylase negative and overexpressing bladder cancer cell lines.
    El-Naggar M; Ebbing E; Bijnsdorp I; van den Berg J; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):413-21. PubMed ID: 24940699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells.
    Weng SH; Tseng SC; Huang YC; Chen HJ; Lin YW
    Biochem Pharmacol; 2012 Jul; 84(1):126-36. PubMed ID: 22480737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
    Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
    J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma.
    Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
    Br J Cancer; 1999 Oct; 81(3):484-9. PubMed ID: 10507774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9.
    Nakajima Y; Haraguchi M; Furukawa T; Yamamoto M; Nakanishi H; Tatematsu M; Akiyama S
    Int J Cancer; 2006 Oct; 119(7):1710-6. PubMed ID: 16646076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; O'Byrne K; Gatter KC; Harris AL
    J Pathol; 2000 Oct; 192(2):140-9. PubMed ID: 11004689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoangiogenesis in patients with gastric carcinoma in relation to the expression of vascular endothelial growth factor and thymidine phosphorylase.
    Tsujitani S; Saito H; Maeta Y; Yamaguchi K; Tatebe S; Kondo A; Kaibara N
    Anticancer Res; 2004; 24(3b):1853-9. PubMed ID: 15274366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased TIP30 expression promotes tumor metastasis in lung cancer.
    Tong X; Li K; Luo Z; Lu B; Liu X; Wang T; Pang M; Liang B; Tan M; Wu M; Zhao J; Guo Y
    Am J Pathol; 2009 May; 174(5):1931-9. PubMed ID: 19349353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft].
    Xiao YS; Zhou J; Tang ZY; Fan J; Wu ZQ; Liu YK; Ye SL; Shen ZZ; Xue Q; Zhao Y
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3205-9. PubMed ID: 16405841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.